Search

Displaying results 6001 - 6010 of 10000 in total
  1. Drug

    Xeligekimab

    go.drugbank.com/drugs/DB18869
    Investigational

    Xeligekimab is under investigation in clinical trial NCT06028490 (A Study of Il4rα Monoclonal Antibody in Patients With Uncontrolled Seasonal Allergic Rhinitis.).

    Synonyms: Immunoglobulin g4 (235-proline), anti-(human interleukin 17a) (human monoclonal gr1501 .gamma.4-chain), disulfide with human monoclonal gr1501 .kappa.-chain, dimer
  2. Drug

    Bertilimumab

    go.drugbank.com/drugs/DB05429
    Investigational

    Bertilimumab is a fully human anti-eotaxin monoclonal antibody with potential in the treatment of allergic disorders, has moved into pre-clinical development.

    Synonyms: IMMUNOGLOBULIN G4, ANTI-(HUMAN EOTAXIN 1) (HUMAN MONOCLONAL CAT-213 .GAMMA.4-CHAIN), DISULFIDE WITH HUMAN MONOCLONAL CAT-213 .KAPPA.-CHAIN, DIMER
  3. Drug

    Linoleic acid

    go.drugbank.com/drugs/DB14104
    Approved

    Mixtures: SIMILAC ALIMENTUM 400 G TOZ, Evening Primrose Oil Cap 500mg W Vit ECategories: Fatty Acids, Omega-6
  4. Drug

    Prednisolone phosphate

    go.drugbank.com/drugs/DB14631
    ApprovedInvestigationalVet approved

    Prednisolone phosphate is a glucocorticoid similar to [cortisol] used for its anti-inflammatory, immunosuppressive, anti-neoplastic, and vasoconstrictive effects.

    Mixtures: OFTALETYC® NFCategories: P-glycoprotein inducers, Cytochrome P-450 CYP2A6 Inducers
  5. Drug

    ACV tripeptide

    go.drugbank.com/drugs/DB02025
    Experimental

    Synonyms: 5-(2-Aminoad)-cys-val, delta(L-2-Aminoadipyl)-L-cysteinyl-D-valine
  6. Drug

    Phenobarbital

    go.drugbank.com/drugs/DB01174
    ApprovedInvestigational

    A barbituric acid derivative that acts as a nonselective central nervous system depressant.

    Mixtures: PIROFEN 200 MG/15 MG SUPPOZITUAR, 5 ADET, Phenaphen No 3 CapCategories: P-glycoprotein substrates with a Narrow Therapeutic Index, Cytochrome P-450 CYP2C18 Substrates with a Narrow Therapeutic Index
  7. Drug

    Ginisortamab

    go.drugbank.com/drugs/DB18863
    Investigational

    Ginisortamab is under investigation in clinical trial NCT04393298 (A Study to Assess the Safety, Pharmacokinetics and Anti Tumor Activity of UCB6114 Administered Intravenously to Participants With Advanced

    Synonyms: Immunoglobulin g4 (232-proline), anti-(human gremlin 1) (human monoclonal ucb6114 .gamma.4-chain), disulfide with human monoclonal ucb6114 .kappa.-chain, dimer
  8. Drug

    Vilamakitug

    go.drugbank.com/drugs/DB18978
    Investigational

    Vilamakitug is under investigation in clinical trial NCT05201352 (Evaluation of Efficacy of Trifluridine/tipiracil Plus an Anti-il-1α True Human Antibody Versus Trifluridine/tipiracil Plus Placebo in Metastatic Colorectal Cancer Patients...

    Synonyms: Immunoglobulin g4, anti-(human interleukin 1.alpha.) (human monoclonal xb2001 .gamma.4-chain), disulfide with human monoclonal xb2001 .kappa.-chain, dimer
  9. Drug

    5-Nitroso-6-ribityl-amino-2,4(1H,3H)-pyrimidinedione

    go.drugbank.com/drugs/DB04128
    Experimental

    Synonyms: 1-Deoxy-1-[(5-nitroso-2,6-dioxo-1,2,3,6-tetrahydro-4-pyrimidinyl)amino]-D-ribitol, 5-Nitroso-6-ribityl-amino-2,4(1H,3H)-pyrimidinedione
  10. Drug

    Bismuth subcitrate potassium

    go.drugbank.com/drugs/DB09275
    ApprovedInvestigational

    A bismuth compound used for peptic ulcer and gastro-oesophageal reflux disease (GORD).

    Mixtures: KATACOLD 120 MG + 3.75 MG+ l MG /5 ML PEDIYATRIK ŞURUP, 100 ML, Pylera 140 mg/125 mg/125 mg HartkapselnProducts: CODACTIV M 15 MG/5 ML ŞURUP, 100 ML, KREVAL7.5 MG/5 ML ŞURUP, 200 ML